Volume 150, Issue 5, Pages e6 (May 2016)

Slides:



Advertisements
Similar presentations
- KLF6 869 bp IHH HepG2 Hep3B HuH bp- 800 bp- 700 bp- 600 bp- SV1 715 bp SV2 743 bp SV3 745 bp IHH HepG2 Hep3B HuH Percentage of.
Advertisements

Volume 64, Issue 3, Pages (March 2016)
Volume 150, Issue 2, Pages e6 (February 2016)
Nutritional therapy for nonalcoholic fatty liver disease
Volume 142, Issue 4, Pages (April 2012)
Volume 148, Issue 4, Pages (April 2015)
PNPLA3 gene in liver diseases
The New England Journal of Medicine (378;12) March 22, 2018
Volume 16, Issue 3, Pages (July 2016)
Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D
Volume 133, Issue 2, Pages (August 2007)
Genetics and epigenetics of NAFLD and NASH
Volume 132, Issue 1, Pages (January 2007)
Volume 143, Issue 5, Pages e7 (November 2012)
Volume 140, Issue 7, Pages (June 2011)
Volume 134, Issue 3, Pages e2 (March 2008)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 15, Issue 5, Pages (May 2012)
C-kit Inhibition by Imatinib Mesylate Attenuates Progenitor Cell Expansion and Inhibits Liver Tumor Formation in Mice  Belinda Knight, Janina E.E. Tirnitz–Parker,
Volume 144, Issue 5, Pages (May 2013)
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia  Piero Pingitore, PhD, Saverio Massimo.
Volume 138, Issue 5, Pages e1 (May 2010)
EPS15R, TASP1, and PRPF3 Are Novel Disease Candidate Genes Targeted by HNF4α Splice Variants in Hepatocellular Carcinomas  Monika Niehof, Jürgen Borlak 
Reduced Expression of Ferroportin-1 Mediates Hyporesponsiveness of Suckling Rats to Stimuli That Reduce Iron Absorption  Deepak Darshan, Sarah J. Wilkins,
Volume 149, Issue 2, Pages (August 2015)
Volume 140, Issue 3, Pages e10 (March 2011)
Volume 137, Issue 4, Pages e5 (October 2009)
Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease  Valerio Nobili, Naim Alkhouri,
Volume 140, Issue 5, Pages (May 2011)
Volume 136, Issue 1, Pages e2 (January 2009)
Volume 136, Issue 2, Pages (February 2009)
Volume 141, Issue 4, Pages e5 (October 2011)
Volume 155, Issue 1, Pages (July 2018)
Volume 140, Issue 5, Pages (May 2011)
TLL1 rs Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C  Miya John, Mayada Metwally  Gastroenterology 
Abstracts from Around the World
Volume 142, Issue 4, Pages (April 2012)
Volume 140, Issue 4, Pages e1 (April 2011)
Mitochondrial Gene Polymorphisms That Protect Mice From Colitis
Volume 140, Issue 3, Pages e2 (March 2011)
Volume 140, Issue 3, Pages e8 (March 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 139, Issue 5, Pages e6 (November 2010)
This Month in Gastroenterology
Volume 143, Issue 2, Pages (August 2012)
Volume 135, Issue 2, Pages (August 2008)
Volume 134, Issue 7, Pages e3 (June 2008)
Volume 136, Issue 1, Pages (January 2009)
Volume 134, Issue 2, Pages (February 2008)
Volume 133, Issue 4, Pages (October 2007)
Volume 137, Issue 4, Pages (October 2009)
Covering the Cover Gastroenterology
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 136, Issue 3, Pages (March 2009)
Volume 138, Issue 3, Pages e3 (March 2010)
Allele-Specific Expression of APC in Adenomatous Polyposis Families
Volume 145, Issue 2, Pages e3 (August 2013)
Association of Nonalcoholic Fatty Liver Disease With Visceral Adiposity but Not Coronary Artery Calcification in the Elderly  Kathleen Jacobs, Sharon.
Fasiha Kanwal, Jennifer R
Volume 139, Issue 5, Pages e3 (November 2010)
Volume 142, Issue 4, Pages e6 (April 2012)
Timothy P. Sheahan, Charles M. Rice  Gastroenterology 
Volume 148, Issue 5, Pages e4 (May 2015)
Volume 135, Issue 1, Pages e1 (July 2008)
Volume 142, Issue 6, Pages e4 (May 2012)
Volume 67, Issue 6, Pages (June 2005)
Volume 131, Issue 5, Pages (November 2006)
Volume 58, Issue 2, Pages (February 2013)
Volume 125, Issue 4, Pages (October 2003)
Volume 135, Issue 6, Pages (December 2008)
Presentation transcript:

Volume 150, Issue 5, Pages 1219-1230.e6 (May 2016) The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent  Rosellina Margherita Mancina, Paola Dongiovanni, Salvatore Petta, Piero Pingitore, Marica Meroni, Raffaela Rametta, Jan Borén, Tiziana Montalcini, Arturo Pujia, Olov Wiklund, George Hindy, Rocco Spagnuolo, Benedetta Maria Motta, Rosaria Maria Pipitone, Antonio Craxì, Silvia Fargion, Valerio Nobili, Pirjo Käkelä, Vesa Kärjä, Ville Männistö, Jussi Pihlajamäki, Dermot F. Reilly, Jose Castro- Perez, Julia Kozlitina, Luca Valenti, Stefano Romeo  Gastroenterology  Volume 150, Issue 5, Pages 1219-1230.e6 (May 2016) DOI: 10.1053/j.gastro.2016.01.032 Copyright © 2016 AGA Institute Terms and Conditions

Figure 1 The MBOAT7-TMC4 rs641738 variant is associated with increased hepatic triglyceride (TG) content in the DHS. The association was tested by linear regression analysis adjusted for age, sex, ethnicity, BMI, IFG/T2DM, PNPLA3 I148M, and TM6SF2 E167K genotype. Data are shown as median value. Numbers in brackets represent interquartile range. Genetic analyses were performed by using an additive model. P value represents the significance of a linear trend in median trait value among genotypes. Gastroenterology 2016 150, 1219-1230.e6DOI: (10.1053/j.gastro.2016.01.032) Copyright © 2016 AGA Institute Terms and Conditions

Figure 2 In the Liver Biopsy Cross-Sectional Cohort, the MBOAT7-TMC4 rs641738 variant is associated with the severity of histologic damage. The histologic damage was evaluated by the different components of NAFLD activity score and with hepatic fibrosis stage. CC, homozygotes for the C allele; CT, heterozygotes; TT, homozygotes for the T allele. The association between the MBOAT7-TMC4 rs641738 variant and the components of the NAS has been tested by multivariate ordinal regression analysis adjusted for age, sex, BMI, presence of IFG/T2DM, number of PNPLA3 I148M alleles, presence of the TM6SF2 E167K variant, and indication of liver biopsy (severe obesity vs nonalcoholic fatty liver with increased liver enzymes). Genetic analyses were calculated by using an additive model, except for TM6SF2 where a dominant model was used due to few homozygotes for the 167K mutant allele. P values represent the significance of a trend in the prevalence of more severe degree of histologic damage among genotypes. Gastroenterology 2016 150, 1219-1230.e6DOI: (10.1053/j.gastro.2016.01.032) Copyright © 2016 AGA Institute Terms and Conditions

Figure 3 MBOAT7 but not TMC4 is highly expressed in human liver and the rs641738 variant is associated with lower circulating levels of phosphatidylinositol 36:4/34:2 ratio. (A) Distribution of MBOAT7 and TMC4 mRNA in 14 human tissues. (B) MBOAT7 and TMC4 mRNA expression in human primary hepatic cell types. Gene expression level was assessed by quantitative polymerase chain reaction. The tissue or the cell line with the highest CT value was assigned the value of 1. (C) Ratio of PI species containing different degree of saturation stratified by the rs643718 C>T genotype in the combined DHS cohort and stratified by the 3 ethnic groups composing the study. HH, human hepatocytes; HHSEC, human hepatic sinusoidal endothelial cell; HSC, hepatic stellate cell. Gastroenterology 2016 150, 1219-1230.e6DOI: (10.1053/j.gastro.2016.01.032) Copyright © 2016 AGA Institute Terms and Conditions

Figure 4 Endogenous MBOAT7 is attached to the ER, mitochondria-associated membrane (MAM), lipid droplets, and MBOAT7-TMC4 rs641738 variant decreases MBOAT7 mRNA expression and synthesis level in liver biopsies of obese patients. (A) Post-nuclear supernatant, cytosol, and ER were obtained by a differential centrifugation. (B) Crude mitochondria were used to isolate purified mitochondria, and MAM by Percoll density gradient. (C) Post-nuclear supernatant was used to isolate lipid droplets by sucrose gradient. (D) Hepatic mRNA levels of MBOAT7 and TMC4 in 98 severely obese stratified by the rs643718 C>T genotype (CC n = 29; CT n = 51; TT n = 18). Data are expressed as fold increase as compared with the protective CC genotype. P = .03 for the effect of the rs641738 T allele on MBOAT7 expression (additive model). Demographic, anthropometric, and clinical characteristics of these patients are shown in Supplementary Table 7. (E) Western blotting analysis and quantification of MBOAT7 protein levels in obese patients carrying the 3 MBOAT7-TMC4 different genotypes, for whom hepatic gene expression was available (Supplementary Table 7). Seven samples for each rs641738 genotype (CC/CT/TT) were collected from liver biopsies and pooled according to genotype. All reactions (25 μg of lysates) were performed in triplicate in the same gel. Data are expressed as fold increase of the 3 MBOAT7 isoforms 1−3 (molecular weight: 52 kDa, 44 kDa, and 38 kDa), as compared with the protective CC genotype. P < .005 (additive model; it represents the difference in the trait examined across MBOAT7 genotypes). ADFP, adipose differentiation-related protein; CNX, calnexin; COX IV, cytochrome c oxidase, Complex IV; FACL4, long-chain acyl-CoA synthetase; IN, infranatant. Gastroenterology 2016 150, 1219-1230.e6DOI: (10.1053/j.gastro.2016.01.032) Copyright © 2016 AGA Institute Terms and Conditions

Supplementary Figure 1 Association between number of PNPLA3, TM6SF2, and MBOAT7 risk variants and hepatic triglyceride (TG) content in DHS. The graph shows mean hepatic triglycerides content by the number of risk alleles (in either gene). Error bars: SEM. Gastroenterology 2016 150, 1219-1230.e6DOI: (10.1053/j.gastro.2016.01.032) Copyright © 2016 AGA Institute Terms and Conditions

Supplementary Figure 2 Recombinant V5-MBOAT7 is attached to the ER, mitochondria-associated membrane (MAM), lipid droplet (LD) in HepG2 stably overexpressing this protein. (A) Post-nuclear supernatant (PNS), cytosol, and ER were obtained by a differential centrifugation. (B) Crude mitochondria were used to isolate purified mitochondria and MAM by Percoll density gradient. (C) Post-nuclear supernatant was used to isolate LDs by sucrose gradient. (D) MBOAT7 mRNA and protein levels in HepG2 cells vs HepG2 stably overexpressing recombinant V5-MBOAT7. ADFP, adipose differentiation-related protein; CNX, calnexin; COX IV, cytochrome c oxidase, Complex IV; FACL4, long-chain acyl-CoA synthetase; IN, infranatant. Gastroenterology 2016 150, 1219-1230.e6DOI: (10.1053/j.gastro.2016.01.032) Copyright © 2016 AGA Institute Terms and Conditions

Supplementary Figure 3 Western blotting analysis and quantification of MBOAT7 protein expression in different hepatic tumor cells: HepG2 and HCC1 (primary cell line37) and in human liver samples, collected from liver biopsies (in duplicate). Equal amounts of proteins (25 μg) was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Bar graph represents the quantification of the 3 MBOAT7 isoforms (52 kDa, 44 kDa, and 38 kDa) and all data were normalized to the beta-actin protein expression. Gastroenterology 2016 150, 1219-1230.e6DOI: (10.1053/j.gastro.2016.01.032) Copyright © 2016 AGA Institute Terms and Conditions